MedPath
NMPA Approval

Brentuximab Vedotin for Injection

S20200008

May 12, 2020

Drug Information

注射用维布妥昔单抗

安适利

注射剂

50mg

生物制品

May 12, 2020

May 11, 2025

Company Information

Applicant Company

Takeda Pharma A/S

Delta Park 45, 2665 Vallensbaek Strand, Denmark

Manufacturing Company

Via Appia Km. 65,561, Latina Scalo (LT), 04013,Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用维布妥昔单抗 - NMPA 批准文号 | MedPath